Loading company…
Marginum develops fluorescence-based systems for detecting tissue during surgery.
Founded in 2020, Marginum develops systems that monitor surgical suction fluids for fluorescence signals and provide feedback on possible tumor traces in resected tissue. The company is based in Tampere, Finland, and raised EUR 2.5 million in pre-Series A funding in August 2025, led by Nostetta Ventures with participation from Redstone, Almaral, Lynx Financial Crime Tech S.A.U., and Business Finland Venture Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in